These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 30665284

  • 1. Optical coherence tomography guided directional atherectomy with antirestenotic therapy for femoropopliteal arterial disease.
    Stavroulakis K, Bisdas T, Torsello G, Argyriou A, Bollenberg L, Schwindt A.
    J Cardiovasc Surg (Torino); 2019 Apr; 60(2):191-197. PubMed ID: 30665284
    [Abstract] [Full Text] [Related]

  • 2. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Isolated Popliteal Artery Lesions.
    Stavroulakis K, Schwindt A, Torsello G, Stachmann A, Hericks C, Bosiers MJ, Beropoulis E, Stahlhoff S, Bisdas T.
    J Endovasc Ther; 2017 Apr; 24(2):181-188. PubMed ID: 28008792
    [Abstract] [Full Text] [Related]

  • 3. Directional Atherectomy With Antirestenotic Therapy vs Drug-Coated Balloon Angioplasty Alone for Common Femoral Artery Atherosclerotic Disease.
    Stavroulakis K, Schwindt A, Torsello G, Beropoulis E, Stachmann A, Hericks C, Bollenberg L, Bisdas T.
    J Endovasc Ther; 2018 Feb; 25(1):92-99. PubMed ID: 29251204
    [Abstract] [Full Text] [Related]

  • 4. Lower Extremity Revascularization Using Optical Coherence Tomography-Guided Directional Atherectomy: Final Results of the EValuatIon of the PantheriS OptIcal COherence Tomography ImagiNg Atherectomy System for Use in the Peripheral Vasculature (VISION) Study.
    Schwindt AG, Bennett JG, Crowder WH, Dohad S, Janzer SF, George JC, Tedder B, Davis TP, Cawich IM, Gammon RS, Muck PE, Pigott JP, Dishmon DA, Lopez LA, Golzar JA, Chamberlin JR, Moulton MJ, Zakir RM, Kaki AK, Fishbein GJ, McDaniel HB, Hezi-Yamit A, Simpson JB, Desai A.
    J Endovasc Ther; 2017 Jun; 24(3):355-366. PubMed ID: 28393673
    [Abstract] [Full Text] [Related]

  • 5. Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE).
    Shammas NW, Shammas GA, Jones-Miller S, Shammas WJ, Bou-Dargham B, Shammas AN, Banerjee S, Rachwan RJ, Daher GE.
    Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):771-777. PubMed ID: 30420096
    [Abstract] [Full Text] [Related]

  • 6. Directional Atherectomy with Antirestenotic Therapy for Femoropopliteal Artery Disease: A Systematic Review and Meta-Analysis.
    Zhen Y, Chang Z, Wang C, Liu Z, Zheng J.
    J Vasc Interv Radiol; 2019 Oct; 30(10):1586-1592. PubMed ID: 31471198
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes.
    Rodoplu O, Oztas DM, Meric M, Beyaz MO, Ulukan MO, Yildiz CE, Unal O, Ugurlucan M.
    Ann Vasc Surg; 2021 May; 73():222-233. PubMed ID: 33359329
    [Abstract] [Full Text] [Related]

  • 8. Mid-term outcomes of orbital atherectomy combined with drug-coated balloon angioplasty for treatment of femoropopliteal disease.
    Foley TR, Cotter RP, Kokkinidis DG, Nguyen DD, Waldo SW, Armstrong EJ.
    Catheter Cardiovasc Interv; 2017 May; 89(6):1078-1085. PubMed ID: 28295971
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease.
    Imran HM, Hyder ON, Soukas PA.
    Cardiovasc Revasc Med; 2019 Mar; 20(3):210-214. PubMed ID: 29970328
    [Abstract] [Full Text] [Related]

  • 10. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis.
    Giannopoulos S, Kokkinidis DG, Jawaid O, Behan S, Hossain P, Alvandi B, Foley TR, Singh GD, Waldo SW, Armstrong EJ.
    Cardiovasc Revasc Med; 2020 Jun; 21(6):771-778. PubMed ID: 31761634
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Two-Year Outcomes of Orbital Atherectomy Combined With Drug-Coated Balloon Angioplasty for Treatment of Heavily Calcified Femoropopliteal Lesions.
    Kokkinidis DG, Jawaid O, Cantu D, Martinsen BJ, Igyarto Z, Valle JA, Waldo SW, Armstrong EJ.
    J Endovasc Ther; 2020 Jun; 27(3):492-501. PubMed ID: 32364000
    [Abstract] [Full Text] [Related]

  • 17. One-Year Clinical Outcomes of the Legflow Drug-Coated Balloon for the Treatment of Femoropopliteal Occlusions Registry.
    Stabile E, Gerardi D, Magliulo F, Zhelev D, Chervenkoff V, Taeymans K, Kotasov D, Goverde P, Giugliano G, Trimarco B, Esposito G.
    J Endovasc Ther; 2019 Feb; 26(1):26-30. PubMed ID: 30760132
    [Abstract] [Full Text] [Related]

  • 18. Network Meta-Analysis of All Available Regimens Based on Drug-Coated Balloon Angioplasty and Laser Atherectomy for Femoropopliteal In-Stent Restenosis.
    Yu C, Tang W, Ren T, Chen Q, Lu R, Gao Y.
    J Endovasc Ther; 2024 Jun; 31(3):390-399. PubMed ID: 36189843
    [Abstract] [Full Text] [Related]

  • 19. Midterm Outcome of Directional Atherectomy Combined with Drug-Coated Balloon Angioplasty Versus Drug-Coated Balloon Angioplasty Alone for Femoropopliteal Arteriosclerosis Obliterans.
    Cai Z, Guo L, Qi L, Cui S, Tong Z, Guo J, Wang Z, Gu Y.
    Ann Vasc Surg; 2020 Apr; 64():181-187. PubMed ID: 31449956
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.